A scientific team has unlocked a new way to treat serious lung conditions by using specially designed nanoparticles to ...

Expert oncologists Dr. Joshua K. Sabari and Dr. Eric K. Singhi break down key updates and takeaways in lung cancer treatment following ASCO 2025.

Thai medical experts unite to combat a projected lung cancer surge, aiming to save over 15,000 lives and cut mortality by 20% ...

Approval was based on results from the Phase II TRUST-I and TRUST-II trials, which demonstrated confirmed overall response rates of up to 90% in patients treated with Ibtrozi for locally advanced or ...

Colorectal cancer is one of the most common types of tumor and is responsible for around 10% of cancer-related deaths ...

Nuvation Bio is set to launch its first commercial product after the FDA approved its ROS1 inhibitor Ibtrozi as a treatment ...

Liquid biopsy becomes available in England A blood test that speeds up cancer diagnosis by two weeks and can help patients with suspected lung or breast cancer receive targeted treatment is now ...

Nuvation Bio Inc., a global oncology company, received U.S. Food and Drug Administration (FDA) approval of Ibtrozi ...

After dropping its only clinical-stage candidate last month, ADC Therapeutics is shutting down a U.K. research site and ...

Nevertheless, colorectal cancer is one of the most common types of tumour and is responsible for around ten percent of cancer-related deaths worldwide. The tumour is particularly dangerous when it ...

Residents will be able to access vital cancer screening information and talk with healthcare professionals from local ...

Inspired by advances in cancer therapy, a team at the Buck Institute has engineered immune cells equipped with specialized targeting devices called chimeric antigen receptors (CARs) that can ...